Unab I Khan1,2, Aileen P McGinn3, Carmen R Isasi3, Adriana Groisman-Perelstein4, Pamela M Diamantis4, Mindy Ginsberg3, Judith Wylie-Rosett3. 1. 1Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY. 2. 2Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, NY. 3. 3Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY. 4. 4Department of Pediatrics, Jacobi Hospital, Bronx, NY.
Abstract
BACKGROUND: It is known that 15-30% overweight/obese adults do not suffer cardiometabolic consequences. There is limited literature examining factors that can be used to assess cardiometabolic health in overweight/obese children. If such factors can be identified, they would aid in differentiating those most in need for aggressive management. METHODS: Baseline data from 7- to 12-year-old, overweight, and obese children enrolled in a weight management program at an urban hospital were analyzed. Homeostatic model assessment for insulin resistance (HOMA-IR) <2.6 was used to define insulin-sensitive and HOMA-IR ≥2.6 was used to defined insulin-resistant participants. Demographics, physical activity measures, and cardiometabolic risk factors were compared between the two phenotypes. Odds ratios (ORs) examining the association between intermediate endpoints (metabolic syndrome [MetS], nonalcoholic fatty liver disease [NAFLD], systemic inflammation, and microalbuminuria) and the two metabolic phenotypes were evaluated. RESULTS: Of the 362 overweight/obese participants, 157 (43.5%) were insulin sensitive and 204 (56.5%) were insulin resistant. Compared to the insulin-sensitive group, the insulin-resistant group was older (8.6±1.6 vs. 9.9±1.7; p<0.001) and had a higher BMI z-score (1.89±0.42 vs. 2.04±0.42; p=0.001). After multivariable adjustment, compared to the insulin-sensitive group, the insulin-resistant group had higher odds of having MetS (OR, 5.47; 95% confidence interval [CI]: 1.72, 17.35; p=0.004) and NAFLD (OR, 8.66; 95% CI, 2.48, 30.31; p=0.001), but not systemic inflammation (OR, 1.06; 95% CI: 0.56, 2.03; p=0.86) or microalbuminuria (OR, 1.71; 95% CI, 0.49, 6.04; p=0.403). CONCLUSIONS: Using a HOMA-IR value of ≥2.6, clinical providers can identify prepubertal and early pubertal children most at risk. Focusing limited resources on aggressive weight interventions may lead to improvement in cardiometabolic health.
BACKGROUND: It is known that 15-30% overweight/obese adults do not suffer cardiometabolic consequences. There is limited literature examining factors that can be used to assess cardiometabolic health in overweight/obesechildren. If such factors can be identified, they would aid in differentiating those most in need for aggressive management. METHODS: Baseline data from 7- to 12-year-old, overweight, and obesechildren enrolled in a weight management program at an urban hospital were analyzed. Homeostatic model assessment for insulin resistance (HOMA-IR) <2.6 was used to define insulin-sensitive and HOMA-IR ≥2.6 was used to defined insulin-resistant participants. Demographics, physical activity measures, and cardiometabolic risk factors were compared between the two phenotypes. Odds ratios (ORs) examining the association between intermediate endpoints (metabolic syndrome [MetS], nonalcoholic fatty liver disease [NAFLD], systemic inflammation, and microalbuminuria) and the two metabolic phenotypes were evaluated. RESULTS: Of the 362 overweight/obeseparticipants, 157 (43.5%) were insulin sensitive and 204 (56.5%) were insulin resistant. Compared to the insulin-sensitive group, the insulin-resistant group was older (8.6±1.6 vs. 9.9±1.7; p<0.001) and had a higher BMI z-score (1.89±0.42 vs. 2.04±0.42; p=0.001). After multivariable adjustment, compared to the insulin-sensitive group, the insulin-resistant group had higher odds of having MetS (OR, 5.47; 95% confidence interval [CI]: 1.72, 17.35; p=0.004) and NAFLD (OR, 8.66; 95% CI, 2.48, 30.31; p=0.001), but not systemic inflammation (OR, 1.06; 95% CI: 0.56, 2.03; p=0.86) or microalbuminuria (OR, 1.71; 95% CI, 0.49, 6.04; p=0.403). CONCLUSIONS: Using a HOMA-IR value of ≥2.6, clinical providers can identify prepubertal and early pubertal children most at risk. Focusing limited resources on aggressive weight interventions may lead to improvement in cardiometabolic health.
Authors: Markus Juonala; Jorma S A Viikari; Tapani Rönnemaa; Leena Taittonen; Jukka Marniemi; Olli T Raitakari Journal: Arterioscler Thromb Vasc Biol Date: 2006-05-25 Impact factor: 8.311
Authors: James B Meigs; Peter W F Wilson; Caroline S Fox; Ramachandran S Vasan; David M Nathan; Lisa M Sullivan; Ralph B D'Agostino Journal: J Clin Endocrinol Metab Date: 2006-05-30 Impact factor: 5.958
Authors: B A Swinburn; B L Nyomba; M F Saad; F Zurlo; I Raz; W C Knowler; S Lillioja; C Bogardus; E Ravussin Journal: J Clin Invest Date: 1991-07 Impact factor: 14.808
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Michelle J Kupka; Warren J Manning; Melvin E Clouse; Ralph B D'Agostino; Peter W F Wilson; Christopher J O'Donnell Journal: Circulation Date: 2002-09-03 Impact factor: 29.690
Authors: Emma Mead; Tamara Brown; Karen Rees; Liane B Azevedo; Victoria Whittaker; Dan Jones; Joan Olajide; Giulia M Mainardi; Eva Corpeleijn; Claire O'Malley; Elizabeth Beardsmore; Lena Al-Khudairy; Louise Baur; Maria-Inti Metzendorf; Alessandro Demaio; Louisa J Ells Journal: Cochrane Database Syst Rev Date: 2017-06-22